Mental Health Technologies Co. Ltd. (JP:9218)
:9218
Want to see JP:9218 full AI Analyst Report?
9218 Stock Chart & Stats
¥820.00
¥48.00(6.48%)
At close: 4:00 PM EST
¥820.00
¥48.00(6.48%)
Day’s Range― - ―
52-Week Range¥638.00 - ¥888.00
Previous CloseN/A
Volume61.50K
Average Volume (3M)54.69K
Market Cap
¥7.21B
Enterprise Value¥9.35B
Total Cash (Recent Filing)¥909.50M
Total Debt (Recent Filing)¥2.38B
Price to Earnings (P/E)30.0
Beta0.74
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)31.70
Shares Outstanding10,507,300
10 Day Avg. Volume35,240
30 Day Avg. Volume54,690
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)5.43
Price to Sales (P/S)1.32
P/FCF Ratio15.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)41.2
Revenue Forecast (FY)¥8.40B
Bulls Say, Bears Say
Bulls Say
Stronger Cash GenerationOperating and free cash flow strengthened materially in 2025 and free cash flow is close to net income. That durable cash generation supports reinvestment, debt reduction or shareholder returns and improves strategic flexibility over the medium term, helping the company fund growth without relying solely on new external financing.
Return To ProfitabilityThe company re-accelerated revenue growth in 2025 and moved back into profitability after a small loss in 2024. Sustained top-line momentum coupled with profitable operations signals improving product-market fit and operational scalability, which can support durable earnings if management maintains discipline on costs and execution.
Solid Revenue Growth TrendReported revenue growth near 18% indicates persistent demand expansion and market penetration. Persistent top-line growth underpins operating leverage and funds long-term investments in products and services, reinforcing the firm's ability to build competitive advantages and expand margins over multiple quarters if trends persist.
Bears Say
Elevated LeverageLeverage rose sharply to a debt-heavy capital structure (debt-to-equity ~1.67 in 2025 after ~2.0 in 2024). Elevated debt levels constrain financial flexibility, increase interest and refinancing risk, and reduce the company's ability to invest or absorb shocks without prioritizing deleveraging over growth initiatives.
Structural Margin CompressionGross margin has meaningfully compressed from mid-60% in 2022 to about 32% in 2025, leaving net margin slim (~4%). This structural erosion reduces operating buffers, heightens sensitivity to cost or revenue shocks, and demands ongoing execution to restore sustainable profitability levels.
Inconsistent Cash Conversion HistoryAlthough 2025 cash flows improved, the company's historical cash conversion has been uneven with negative OCF/FCF in earlier years and weaker coverage in 2024. This volatility raises the risk that cash generation may revert under stress, complicating planning for capex, R&D, or debt servicing over the medium term.
9218 FAQ
What was Mental Health Technologies Co. Ltd.’s price range in the past 12 months?
Mental Health Technologies Co. Ltd. lowest stock price was ¥638.00 and its highest was ¥888.00 in the past 12 months.
What is Mental Health Technologies Co. Ltd.’s market cap?
Mental Health Technologies Co. Ltd.’s market cap is ¥7.21B.
When is Mental Health Technologies Co. Ltd.’s upcoming earnings report date?
Mental Health Technologies Co. Ltd.’s upcoming earnings report date is Aug 19, 2026 which is in 72 days.
How were Mental Health Technologies Co. Ltd.’s earnings last quarter?
Mental Health Technologies Co. Ltd. released its earnings results on May 15, 2026. The company reported ¥5.21 earnings per share for the quarter, beating the consensus estimate of N/A by ¥5.21.
Is Mental Health Technologies Co. Ltd. overvalued?
According to Wall Street analysts Mental Health Technologies Co. Ltd.’s price is currently Overvalued.
Does Mental Health Technologies Co. Ltd. pay dividends?
Mental Health Technologies Co. Ltd. pays a Notavailable dividend of ¥9.922 which represents an annual dividend yield of N/A. See more information on Mental Health Technologies Co. Ltd. dividends here
What is Mental Health Technologies Co. Ltd.’s EPS estimate?
Mental Health Technologies Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mental Health Technologies Co. Ltd. have?
Mental Health Technologies Co. Ltd. has 10,507,300 shares outstanding.
What happened to Mental Health Technologies Co. Ltd.’s price movement after its last earnings report?
Mental Health Technologies Co. Ltd. reported an EPS of ¥5.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.01%.
Which hedge fund is a major shareholder of Mental Health Technologies Co. Ltd.?
Currently, no hedge funds are holding shares in JP:9218
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mental Health Technologies Co. Ltd.
Mental Health Technologies Co.,Ltd. engages in mental health solutions, physician career support, and digital marketing businesses in Japan. It is also involved in industrial physician cloud business. The company was incorporated in 2011 and is headquartered in Tokyo, Japan.